MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population

Wouter J P Henneman1, Jasper D Sluimer, Charlotte Cordonnier

  • 1Department of Radiology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands. w.henneman@vumc.nl

Stroke
|December 26, 2008
PubMed
Abstract

Insights

Simple MRI scans can predict mortality risk in memory clinic patients. Microbleeds and white matter changes are key indicators, offering prognostic value beyond diagnosis.

Area of Science:

  • Neurology
  • Radiology
  • Geriatrics

Background:

  • Magnetic Resonance Imaging (MRI) biomarkers are crucial for diagnosing dementia.
  • The prognostic implications of these MRI findings, particularly for mortality risk, are less understood.
  • Memory clinic populations represent a diverse group with various cognitive complaints and diagnoses.

Purpose of the Study:

  • To evaluate the prognostic value of simple Magnetic Resonance Imaging (MRI) rating scales in predicting mortality.
  • To determine if visual assessment of brain atrophy and white matter changes can identify patients at higher risk of death.
  • To investigate specific MRI markers associated with increased mortality in a memory clinic setting.

Main Methods:

  • A cohort of 1138 memory clinic patients with diagnoses including subjective complaints, mild cognitive impairment, Alzheimer's disease, and vascular dementia were included.
  • Baseline MRI scans were assessed using visual rating scales for medial temporal lobe atrophy, global cortical atrophy, and white matter hyperintensities.
  • Cox-regression models were employed to analyze the association between MRI markers and mortality risk, adjusting for demographic and diagnostic factors.

Main Results:

  • In a mean follow-up of 2.6 years, white matter hyperintensities and microbleeds significantly predicted mortality after adjusting for confounders.
  • White matter hyperintensities (HR, 1.2) and microbleeds (HR, 1.02) were independently associated with increased mortality risk.
  • Global cortical atrophy predicted mortality primarily in younger individuals, and an interaction between microbleeds and global cortical atrophy indicated particularly high mortality risk.

Conclusions:

  • Simple MRI biomarkers possess significant prognostic value for mortality in memory clinic patients, extending beyond their diagnostic utility.
  • Microbleeds emerged as the strongest independent predictor of mortality in this cohort.
  • These findings highlight the potential of routine MRI assessments to identify individuals at elevated risk of death, aiding in clinical management.